More about

Headache

News
September 02, 2022
1 min read
Save

Diamond Headache Clinic to present migraine tracks at PAINWeek, BRAINWeek 2022

Diamond Headache Clinic to present migraine tracks at PAINWeek, BRAINWeek 2022

The 2022 PAINWeek and BRAINWeek conferences, Sept. 6-9 and Sept. 28-30 in Las Vegas, will feature migraine tracks presented by the world-renowned Diamond Headache Clinic.

News
August 09, 2022
1 min read
Save

Fatigue, headache most common long COVID symptoms

Fatigue, headache most common long COVID symptoms

Fatigue and headache were the most common symptoms reported by people an average of 4 months after COVID-19 infection, according to research in Brain, Behavior, & Immunity.

News
June 29, 2022
2 min read
Save

Acupuncture effective in treating symptoms of chronic tension-type headache

Acupuncture effective in treating symptoms of chronic tension-type headache

An 8-week course of true acupuncture reduced the monthly number of headache days in patients with chronic tension-type headache, with treatment effects lasting for 32 weeks, according to a study published in Neurology.

News
June 16, 2022
2 min watch
Save

VIDEO: Migraine prevalence stable, burden on rise throughout U.S.

VIDEO: Migraine prevalence stable, burden on rise throughout U.S.

DENVER — Although migraine prevalence has remained stable over the past 30 years, measures of burden, including MIDAS scores, have steadily increased, Fred Cohen, MD, said at the American Headache Society’s annual scientific meeting.

News
June 13, 2022
1 min read
Save

Fewer monthly migraine days observed after 6 months of Vyepti vs. placebo

Fewer monthly migraine days observed after 6 months of Vyepti vs. placebo

DENVER — Treatment with Vyepti was associated with a sustained reduction in the frequency of episodic and chronic migraines over 6 months, researchers reported at the American Headache Society annual scientific meeting.

News
June 11, 2022
1 min read
Save

Trudhesa nasal spray shows efficacy for migraines in phase 3 trial

Trudhesa nasal spray shows efficacy for migraines in phase 3 trial

DENVER — Trudhesa nasal spray provided pain relief for up to three consecutive migraine attacks in an open-label, 52-week phase 3 trial, researchers said at the American Headache Society annual scientific meeting.

News
June 10, 2022
1 min read
Save

Psilocybin use effective in treating cluster headaches, migraines

Psilocybin use effective in treating cluster headaches, migraines

DENVER — Psychedelic use, specifically psilocybin, is effective in treating cluster headaches and migraines, Emmanuelle Schindler, MD, PhD, said at the American Headache Society annual scientific meeting.

News
April 27, 2022
2 min read
Save

Racial, ethnic disparities evident in management of postdural puncture headache

Racial, ethnic disparities evident in management of postdural puncture headache

A cross-sectional study published in JAMA Network Open revealed significant racial and ethnic disparities in the management of postdural puncture headache using epidural blood patches, which may be associated with long-term adverse effects.

News
April 21, 2022
2 min read
Save

Cognitive impairment, headaches, CVD more common in former college football players

Cognitive impairment, headaches, CVD more common in former college football players

Former college football players had a significantly higher prevalence of several health issues later in life than nonplayers, according to findings published in JAMA Network Open.

News
January 24, 2022
1 min read
Save

Nerve stimulation intervention may reduce number of headache days in migraine patients

Nerve stimulation intervention may reduce number of headache days in migraine patients

Commercial-stage bioelectronic medicine company electroCore Inc. announced its noninvasive vagus nerve stimulation intervention for migraine prevention reduced the number of monthly headache days.

View more